Furukawa M - Search Results

1

[Concurrent chemoradiotherapy for resectable locoregionally advanced squamous cell carcinoma of the head and neck-analysis of factors associated with toxicity and efficacy].

Kubota A, Furukawa M, Fujita Y, Yagi H. Kubota A, et al. Among authors: furukawa m. Nihon Jibiinkoka Gakkai Kaiho. 2010 Mar;113(3):101-9. doi: 10.3950/jibiinkoka.113.101. Nihon Jibiinkoka Gakkai Kaiho. 2010. PMID: 20387597 Japanese.

2

[Fine needle aspiration cytology under ultrasonographic imaging].

Furukawa M, Furukawa MK, Tsukuda M, Yamashita K, Ito K. Furukawa M, et al. Among authors: furukawa mk. Nihon Jibiinkoka Gakkai Kaiho. 1993 Jan;96(1):107-14. doi: 10.3950/jibiinkoka.96.107. Nihon Jibiinkoka Gakkai Kaiho. 1993. PMID: 8459304 Japanese.

3

[Telomerase activity of tumors in the head and neck].

Kagata HY, Tsukuda M, Mochimatsu I, Kubota A, Furukawa MK, Yasumoto S. Kagata HY, et al. Among authors: furukawa mk. Nihon Jibiinkoka Gakkai Kaiho. 1998 Feb;101(2):205-11. doi: 10.3950/jibiinkoka.101.205. Nihon Jibiinkoka Gakkai Kaiho. 1998. PMID: 9545766 Japanese.

4

Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.

Kawano T, Nakamura Y, Yanoma S, Kubota A, Furukawa M, Miyagi Y, Tsukuda M. Kawano T, et al. Among authors: furukawa m. Auris Nasus Larynx. 2004 Mar;31(1):35-41. doi: 10.1016/j.anl.2003.09.005. Auris Nasus Larynx. 2004. PMID: 15041052

5

[Nedaplatin for recurrent cancer of the head and neck].

Kubota A, Furukawa M, Kawano T, Komatsu M. Kubota A, et al. Among authors: furukawa m. Nihon Jibiinkoka Gakkai Kaiho. 2004 May;107(5):475-82. doi: 10.3950/jibiinkoka.107.475. Nihon Jibiinkoka Gakkai Kaiho. 2004. PMID: 15198007 Japanese.

6

Reovirus oncolysis in human head and neck squamous carcinoma cells.

Ikeda Y, Nishimura G, Yanoma S, Kubota A, Furukawa M, Tsukuda M. Ikeda Y, et al. Among authors: furukawa m. Auris Nasus Larynx. 2004 Dec;31(4):407-12. doi: 10.1016/j.anl.2004.07.003. Auris Nasus Larynx. 2004. PMID: 15571915

7

[Concurrent chemoradiotherapy for head and neck squamous cell carcinoma with indication of total laryngectomy].

Kubota A, Furukawa M, Komatsu M. Kubota A, et al. Among authors: furukawa m. Nihon Jibiinkoka Gakkai Kaiho. 2004 Nov;107(11):1004-10. doi: 10.3950/jibiinkoka.107.1004. Nihon Jibiinkoka Gakkai Kaiho. 2004. PMID: 15624506 Japanese.

8

Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.

Kawano T, Yanoma S, Nakamura Y, Ozeki A, Kokatsu T, Kubota A, Furukawa M, Tsukuda M. Kawano T, et al. Among authors: furukawa m. Acta Otolaryngol. 2005 Apr;125(4):392-7. doi: 10.1080/00016480510026971. Acta Otolaryngol. 2005. PMID: 15823810

9

Expression of SPARC in tongue carcinoma of stage II is associated with poor prognosis: an immunohistochemical study of 86 cases.

Kato Y, Nagashima Y, Baba Y, Kawano T, Furukawa M, Kubota A, Yanoma S, Imagawa-Ishiguro Y, Satake K, Taguchi T, Hata R, Mochimatsu I, Aoki I, Kameda Y, Inayama Y, Tsukuda M. Kato Y, et al. Among authors: furukawa m. Int J Mol Med. 2005 Aug;16(2):263-8. Int J Mol Med. 2005. PMID: 16012759

10

Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.

Kawano T, Yanoma S, Nakamura Y, Shiono O, Kokatu T, Kubota A, Furukawa M, Tsukuda M. Kawano T, et al. Among authors: furukawa m. Am J Otolaryngol. 2005 Sep-Oct;26(5):308-13. doi: 10.1016/j.amjoto.2005.02.005. Am J Otolaryngol. 2005. PMID: 16137528

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,474 results

Search Page

Filters